Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

University of Minnesota

University of Minnesota in Minneapolis, Minnesota, United States is listed as a site for 1,682 registered clinical trials, 443 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,682
Ongoing 443

This page covers the site record University of Minnesota in Minneapolis, Minnesota, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, University of Minnesota, also sponsors trials.

Get the University of Minnesota report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,682 trials counted.

  • Phase 1 120 trials
  • Phase 1/2 82 trials
  • Phase 2 264 trials
  • Phase 2/3 32 trials
  • Phase 3 283 trials
  • Phase 4 80 trials
  • Not applicable 450 trials
  • Observational 362 trials
  • Expanded access 9 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 444 trials
  • Completed 982 trials
  • Terminated 217 trials
  • Other 39 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 115

1992: 1 trials (Phase 2/3 1) 1993: 2 trials (Observational 1, Phase 1 1) 1994: 1 trials (Phase 3 1) 1995: 5 trials (Observational 2, Phase 3 1, Phase 2 2) 1996: 4 trials (Observational 1, Phase 2 1, Phase 1 2) 1997: 7 trials (Observational 1, Phase 4 2, Phase 3 1, Phase 2 2, Phase 1 1) 1998: 6 trials (Not applicable 1, Phase 4 1, Phase 2 4) 1999: 8 trials (Not applicable 1, Phase 4 1, Phase 3 3, Phase 2 3) 2000: 8 trials (Observational 1, Not applicable 1, Phase 4 3, Phase 3 1, Phase 1/2 2) 2001: 9 trials (Observational 3, Not applicable 2, Phase 3 1, Phase 2/3 1, Phase 2 1, Phase 1/2 1) 2002: 13 trials (Observational 2, Not applicable 2, Phase 4 3, Phase 3 4, Phase 2 2) 2003: 22 trials (Observational 1, Not applicable 1, Phase 4 2, Phase 3 9, Phase 2 4, Phase 1/2 2, Phase 1 3) 2004: 28 trials (Observational 2, Not applicable 9, Phase 4 1, Phase 3 5, Phase 2/3 2, Phase 2 8, Phase 1 1) 2005: 41 trials (Observational 10, Not applicable 6, Phase 4 2, Phase 3 11, Phase 2/3 2, Phase 2 7, Phase 1/2 2, Phase 1 1) 2006: 32 trials (Observational 5, Not applicable 3, Phase 4 5, Phase 3 10, Phase 2 6, Phase 1/2 2, Phase 1 1) 2007: 37 trials (Observational 7, Not applicable 2, Phase 4 3, Phase 3 9, Phase 2/3 1, Phase 2 10, Phase 1/2 2, Phase 1 3) 2008: 34 trials (Observational 10, Not applicable 6, Phase 3 5, Phase 2/3 1, Phase 2 8, Phase 1/2 3, Phase 1 1) 2009: 46 trials (Observational 9, Not applicable 10, Phase 3 11, Phase 2/3 1, Phase 2 13, Phase 1/2 1, Phase 1 1) 2010: 56 trials (Observational 19, Not applicable 2, Phase 4 3, Phase 3 11, Phase 2/3 3, Phase 2 15, Phase 1/2 1, Phase 1 2) 2011: 48 trials (Observational 15, Not applicable 12, Phase 4 2, Phase 3 7, Phase 2 7, Phase 1/2 3, Phase 1 2) 2012: 51 trials (Observational 17, Not applicable 16, Phase 4 2, Phase 3 5, Phase 2 3, Phase 1/2 3, Phase 1 5) 2013: 54 trials (Observational 13, Not applicable 18, Phase 4 3, Phase 3 6, Phase 2/3 2, Phase 2 6, Phase 1/2 4, Phase 1 2) 2014: 61 trials (Observational 16, Not applicable 13, Phase 4 2, Phase 3 12, Phase 2 10, Phase 1/2 3, Phase 1 5) 2015: 73 trials (Observational 21, Not applicable 14, Phase 4 5, Phase 3 13, Phase 2/3 2, Phase 2 16, Phase 1 2) 2016: 70 trials (Observational 21, Not applicable 13, Phase 4 5, Phase 3 10, Phase 2/3 2, Phase 2 11, Phase 1/2 2, Phase 1 6) 2017: 91 trials (Observational 18, Not applicable 24, Phase 4 3, Phase 3 15, Phase 2/3 1, Phase 2 19, Phase 1/2 6, Phase 1 5) 2018: 89 trials (Observational 24, Not applicable 21, Phase 4 1, Phase 3 15, Phase 2/3 1, Phase 2 13, Phase 1/2 9, Phase 1 5) 2019: 108 trials (Observational 26, Not applicable 41, Phase 4 6, Phase 3 12, Phase 2 12, Phase 1/2 3, Phase 1 8) 2020: 70 trials (Observational 12, Not applicable 24, Phase 4 2, Phase 3 12, Phase 2 14, Phase 1/2 3, Phase 1 3) 2021: 103 trials (Observational 20, Not applicable 36, Phase 4 2, Phase 3 17, Phase 2/3 2, Phase 2 15, Phase 1/2 4, Phase 1 7) 2022: 112 trials (Observational 25, Not applicable 36, Phase 4 6, Phase 3 19, Phase 2/3 2, Phase 2 9, Phase 1/2 5, Phase 1 10) 2023: 99 trials (Observational 18, Not applicable 31, Phase 4 3, Phase 3 17, Phase 2/3 1, Phase 2 12, Phase 1/2 4, Phase 1 13) 2024: 115 trials (Observational 22, Not applicable 35, Phase 4 7, Phase 3 16, Phase 2/3 2, Phase 2 13, Phase 1/2 4, Phase 1 16) 2025: 87 trials (Observational 10, Not applicable 37, Phase 4 2, Phase 3 11, Phase 2/3 2, Phase 2 10, Phase 1/2 7, Phase 1 8)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 69
2025 87
2024 115
2023 99
2022 112
2021 103
2020 70
2019 108
2018 89
2017 91

Showing 10 of 35 years.

Start your 14-day trial Email me all 35 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 4 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,682 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 324 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 743 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF